NGS-based monitoring of secondary acute lymphoblastic leukemia dynamics following lenalidomide maintenance in multiple myeloma patients.
1/5 보강
We report on a series of three patients diagnosed with secondary acute lymphoblastic leukemia (sALL) following treatment for multiple myeloma (MM) where serial, commercially available, next-generation
APA
Calvillo CD, Cardenas Castro V, et al. (2026). NGS-based monitoring of secondary acute lymphoblastic leukemia dynamics following lenalidomide maintenance in multiple myeloma patients.. Leukemia & lymphoma, 67(2), 342-348. https://doi.org/10.1080/10428194.2025.2586084
MLA
Calvillo CD, et al.. "NGS-based monitoring of secondary acute lymphoblastic leukemia dynamics following lenalidomide maintenance in multiple myeloma patients.." Leukemia & lymphoma, vol. 67, no. 2, 2026, pp. 342-348.
PMID
41257444 ↗
Abstract 한글 요약
We report on a series of three patients diagnosed with secondary acute lymphoblastic leukemia (sALL) following treatment for multiple myeloma (MM) where serial, commercially available, next-generation sequencing (NGS) based tracking of measurable residual disease (MRD) using the clonoSEQ assay provided valuable clinical insight. Each of the patients in this series had been treated for their MM with regimens that had included autologous stem cell transplantation following high dose melphalan chemotherapy and had been on maintenance treatment with the immunomodulatory drug lenalidomide for at least one year.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
- Humans
- Multiple Myeloma
- Lenalidomide
- High-Throughput Nucleotide Sequencing
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Neoplasm
- Residual
- Middle Aged
- Male
- Female
- Aged
- Antineoplastic Combined Chemotherapy Protocols
- Maintenance Chemotherapy
- Neoplasms
- Second Primary
- Hematopoietic Stem Cell Transplantation
- Multiple myeloma
- acute lymphoblastic leukemia
- clonoSEQ
- measurable residual disease
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.